News & Updates
Filter by Specialty:
Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
05 Nov 2021
byAudrey Abella
Use of the oral antiandrogen chlormadinone at a low dose led to improvements in persistence rate of active surveillance (AS), PSA* and testosterone levels and prostate volume, and quality of life (QoL) in men with low-risk prostate cancer (PCa), the PROSAS study has shown.
Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
05 Nov 2021
Nerve block may provide relief for pancreatic cancer pain
04 Nov 2021
byAudrey Abella
Neurolytic splanchnic nerve block (SNB) appears effective for pain control in patients with moderate-to-severe pain due to unresectable pancreatic cancer, a study has shown.
Nerve block may provide relief for pancreatic cancer pain
04 Nov 2021
RS-RARP confers better continence outcomes than conventional RARP
03 Nov 2021
In prostate cancer patients, retzius-sparing robotic-assisted radical prostatectomy (RS-RARP) yields better continence outcomes compared with conventional RARP, a recent study has found.
